Showing results (1-10 of 7,888) with videos related to

Sort By:
Pageof 789
Molecular Immunology|August 27, 2023
FcγRIIB expression increases during primary biliary cholangitisXiuzhu Gao, Heming Ma, Junqi Niu, et al.
Frontiers in Cell and Developmental Biology|April 25, 2022
miR-654-5p Contributes to the Activation and Proliferation of Hepatic Stellate Cells by Targeting RXRαHeming Ma, Xiaomei Wang, Xu Liu, et al.
International Immunopharmacology|February 9, 2025
Activation of immune checkpoint OX40 inhibits HBV replication in a mouse modelMengru Zhan, Shaoling Zhong, Junqi Niu, et al.
Molecular Biology Reports|March 17, 2021
Liver sinusoidal endothelial cells are implicated in multiple fibrotic mechanismsHeming Ma, Xu Liu, Mingyuan Zhang, et al.
Journal of Hepatocellular Carcinoma|December 10, 2020
Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCCXiuzhu Gao, Mengru Zhan, Liquan Wang, et al.
International Immunopharmacology|October 19, 2024
Diammonium glycyrrhizinate ameliorates alcohol-induced liver injury by reducing oxidative stress, steatosis, and inflammationXiaomei Wang, Xiuzhu Gao, Fang Xu, et al.
European Journal of Gastroenterology & Hepatology|February 21, 2018
Primary biliary cholangitis is more severe in previous hepatitis B virus infection patientsYingyu Zhang, Ying Shi, Ruihong Wu, et al.
European Journal of Medical Research|November 2, 2023
Soluble immune checkpoints are elevated in patients with primary biliary cholangitisXiuzhu Gao, Xiaomei Wang, Yazhe Guan, et al.
Frontiers in Microbiology|April 25, 2022
Multiple Regions Drive Hepatitis Delta Virus Proliferation and Are Therapeutic TargetsJun Zi, Xiuzhu Gao, Juan Du, et al.
Mediators of Inflammation|May 16, 2020
IL-33 Inhibits Hepatitis B Virus through Its Receptor ST2 in Hydrodynamic HBV Mouse ModelXiuzhu Gao, Xiumei Chi, Xiaomei Wang, et al.
Pageof 789